Signum Biosciences launched Epicutis, a professional, medical-grade luxury skincare line with two products, Lipid Serum and HYVIA Crème. The Lipid Serum features Epicutis's novel patented ingredient, TSC, to improve skin health, while re-texturizing the surface of the skin for a smoother feel and the HYVIA Crème, features HYVIA, a patented chia seed oil extract. HYVIA is a moisturizer that works to improves hydration on the cellular level while strengthening the skin's barrier. Epicutis products are formulated with non-toxic, high-quality, patented active ingredients and utilizing technology discovered by Dr. Jeffry Stock, a professor of molecular biology at Princeton University, Stock worked with scientist and formulator Masanori Tamura, who has over 10 years of formulation experience in Japan, to develop Epicutis. "The skincare industry in the United States is not subject to the same regulatory controls as in western Europe or Japan," says Maxwell Stock, CEO and founder of Signum Biosciences. "Consumers are rarely aware of what is behind the products they use to nourish and protect their skin. Our team of scientists has always been focused on transparency and we are excited to bring this same guarantee to the professional medical world with our best-in-class formulas."
Epicutis products are available only through clinician's offices. To locate one near you, visit www.epicutis.com/schedule-consultation.
Related Articles
5 Tips for Treating Fungal Acne
Bel’Océane Paris Launches in U.S.
House of Grō is Now Available at Esencia Wellness Spa